Oncotarget

Research Papers:

Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer

Jian Shu, Hanjie Yu, Xiaojie Li, Dandan Zhang, Xiawei Liu, Haoqi Du, Jiaxu Zhang, Zhao Yang, Hailong Xie and Zheng Li _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:35718-35727. https://doi.org/10.18632/oncotarget.16082

Metrics: PDF 1445 views  |   HTML 1636 views  |   ?  


Abstract

Jian Shu1,*, Hanjie Yu1,*, Xiaojie Li2,*, Dandan Zhang1, Xiawei Liu1, Haoqi Du1, Jiaxu Zhang1, Zhao Yang1, Hailong Xie3, Zheng Li1

1Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an, China

2Department of Pothology. First People`s Hospital of Chenzhou, Chenzhou, China

3Institute of Cancer Research, University of South China, Hengyang, China

*These authors contributed equally to this work

Correspondence to:

Zheng Li, email: zhengli@nwu.edu.cn

Hailong Xie, email: xhl0078@sina.com.cn

Keywords: salivary glycopatterns, gastric cancer, biomarker, diagnostic models

Received: January 17, 2017     Accepted: February 28, 2017     Published: March 10, 2017

ABSTRACT

Gastric cancer (GC) is still an extremely severe health issue with high mortality due to the lacking of effective biomarkers. In this study, we aimed to investigate the alterations of salivary protein glycosylation related to GC and assess the possibility of salivary glycopatterns as potential biomarkers for the diagnosis of GC. Firstly, 94 patients with GC (n = 64) and atrophic gastritis (AG) (n = 30), as well as 30 age- and sex-matched healthy volunteers (HV) were enrolled in the test group to probe the difference of salivary glycopatterns using lectin microarrays, the results were validated by saliva microarrays and lectin blotting analysis. Then, the diagnostic model of GC (Model GC) and AG (Model AG) were constructed based on 15 candidate lectins which exhibited significant alterations of salivary glycopattern by logistic stepwise regression. Finally, two diagnostic models were assessed in the validation group including HV (n = 30) and patients with GC (n = 23) and AG (n = 24) and achieved high diagnostic power (Model GC (AUC: 0.89, sensitivity: 0.96 and specificity: 0.80), Model AG (AUC: 0.83, sensitivity: 0.92 and specificity: 0.72)). This study provides pivotal information to distinguish HV, AG and GC based on precise alterations in salivary glycopatterns, which have great potential to be biomarkers for diagnosis of GC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 16082